Orbis Allan Gray »

Dyne Therapeutics shares owned by Orbis Allan Gray

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Orbis Allan Gray from 13F filings

Historical chart of Orbis Allan Gray investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Orbis Allan Gray consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Orbis Allan Gray

Quarter filed Position value Share count Share price at filing
2025-12-31 $94M 4.8M 19.56

More positions owned by Orbis Allan Gray

Qxo Com New (QXO)
Corpay Com Shs (CPAY)
UnitedHealth (UNH)
Alphabet Cap Stk Cl A (GOOGL)
Icon SHS (ICLR)
Insmed Com Par $.01 (INSM)
Gxo Logistics Incorporated Common Stock (GXO)
Bruker Corporation (BRKR)
Alnylam Pharmaceuticals (ALNY)
Newmont Mining Corporation (NEM)
Interactive Brokers Group In Com Cl A (IBKR)
Itau Unibanco Hldg S A Spon Adr Rep Pfd (ITUB)
Steris Shs Usd (STE)
Smurfit Westrock SHS (SW)
British Amern Tob Sponsored Adr (BTI)

View all positions for Orbis Allan Gray

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
Vanguard Group
BlackRock
Atlas Venture Life Science Advisors
State Street Corporation
Fcpm Iii Services B.v.
FMR
Orbis Allan Gray
Siren
TCG Crossover Management
Adage Capital Partners GP
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management

View all funds holding Dyne Therapeutics